• Hydrocortisone Workflows for Inflammation Models

  2026-08-25

  Hydrocortisone provides a physiologically relevant glucocorticoid hormone benchmark for linking receptor signaling with endothelial barrier function, inflammatory gene expression, and neuroprotection. This practical workflow also adapts assay logic from diabetic fibroblast research to improve experimental controls without overstating cross-domain evidence.

• Muscle BDNF Release in Early NMJ Formation

  2026-08-25

  The reference study identifies podosome-like structures as specialized sites where skeletal muscle cells traffic, capture, process, and locally release BDNF during the earliest stages of neuromuscular junction development. Combining live-cell imaging, molecular perturbation, and muscle-specific BDNF knockout mice, it shows that localized muscle-derived BDNF is required for initial acetylcholine receptor clustering and subsequent postsynaptic assembly.

• 3-Aminobenzamide: An Assay-First PARP Strategy

  2026-08-24

  3-Aminobenzamide (PARP-IN-1) is a practical tool for dissecting how PARP-dependent ADP-ribosylation shapes oxidative, vascular, renal, and antiviral phenotypes. This assay-first guide connects product parameters with causal controls and the coronavirus macrodomain literature.

• Amikacin–Lysozyme Binding: Multimodal Evidence

  2026-08-24

  A 2024 study combined tritium probing, interfacial measurements, fluorescence spectroscopy, enzymatic assays, and molecular docking to define how amikacin and levofloxacin interact with lysozyme. The results distinguish preservation of protein secondary structure from major functional effects, showing that amikacin nearly eliminates lysozyme activity whereas levofloxacin can bind favorably without perturbing key catalytic residues.

• Localized Muscle BDNF Shapes Early NMJ Assembly

  2026-08-23

  The reference study shows that muscle-generated BDNF is not merely a diffusible trophic factor: it is trafficked to podosome-like structures, released in an activity- and calcium-dependent manner, and proteolytically processed to regulate early acetylcholine receptor organization at neuromuscular junctions. By combining live-cell imaging, molecular perturbation, and muscle-specific knockout mice, the work identifies localized BDNF signaling as a mechanistic checkpoint in postsynaptic assembly.

• MitMAB for Endocytosis Assays in Intestinal Organoids

  2026-08-22

  MitMAB enables polarity-aware analysis of dynamin-dependent uptake in intestinal organoids. This article translates milk-derived extracellular vesicle findings into a practical framework for causal endocytosis and intracellular trafficking research.

• Gentamycin Sulfate: From Ribosome to Resistance

  2026-08-22

  Gentamycin Sulfate is an aminoglycoside antibiotic for connecting ribosomal decoding errors with resistance phenotypes. This article presents an assay-design framework informed by comparative susceptibility testing in resistant Gram-negative pathogens.

• Sodium Ascorbate: From ROS to Assay Design

  2026-08-21

  Sodium Ascorbate is a mineral salt of ascorbic acid used to study oxidative-stress-driven cancer phenotypes. This article connects its ROS biology and glioblastoma evidence with biomarker-aware assay design while clarifying practical limitations and research-only use.

• Ruthenium Red for Calcium Mechanotransduction

  2026-08-20

  Use Ruthenium Red as a water-soluble Ca2+ transport inhibitor to test whether calcium flux contributes to compression-induced autophagy. This workflow connects cytoskeletal mechanotransduction with mitochondrial calcium uptake inhibition and provides practical controls for separating calcium effects from general toxicity or altered autophagy flux.

• Tofacitinib Repairs RA Macrophage Dysfunction

  2026-08-20

  A 2026 study identifies a GM-CSF-driven macrophage state in rheumatoid arthritis that couples inflammatory activation to oxidative stress and mitochondrial fragmentation. It shows that tofacitinib, unlike selected metabolic interventions, broadly restores regulatory, metabolic, and mitochondrial features through suppression of GM-CSFRα-associated STAT5 signaling.

• Paroxetine, Histone Serotonylation, and Melanoma Pyroptosis

  2026-08-19

  Li et al. identify paroxetine hydrochloride as a repurposing candidate that induces pyroptosis in BRAF V600E-mutated melanoma, including models resistant to BRAF and MEK inhibitors. The study links 5-HT reuptake blockade to reduced H3Q5 serotonylation at DNA-repair gene promoters, genomic instability, proteostasis stress, and enhanced anti-PD-1 activity in preclinical models.

• Chloroquine Diphosphate in Autophagy Assays

  2026-08-19

  Chloroquine Diphosphate offers a water-soluble way to interrogate late autophagy, treatment resistance, and cell-death crosstalk without introducing DMSO. This workflow-focused guide shows how to use SKU A8628 in dose-response studies, chemotherapy sensitization, radiotherapy sensitization, and mechanistic cancer research.

• BODIPY 581/591 C11: Reliable Lipid Assays

  2026-08-18

  Learn how BODIPY 581/591 C11 (SKU C8003) supports ratiometric lipid peroxidation detection in live-cell oxidative stress and ferroptosis workflows. This scenario-based guide covers assay design, protocol optimization, interpretation, controls, and practical product selection.

• ATS-9R: Designing Better Adipose Gene-Silencing Studies

  2026-08-18

  ATS-9R enables targeted nucleic acid delivery to white adipose tissue through Prohibitin-mediated uptake and nona-arginine condensation. This guide focuses on the assay-design decisions that connect particle formation, visceral adipose targeting, macrophage biology, and metabolic endpoints.

• BCKAs Activate HIF1α Signaling in Normoxia

  2026-08-17

  This preprint identifies branched-chain α-ketoacids (BCKAs) as paracrine metabolic signals that activate HIF1α in vascular cells despite ambient oxygen levels. Its findings connect BCKA metabolism, PHD2 inhibition, L2HG production, glycolytic remodeling, and pulmonary artery smooth muscle cell phenotypic switching, providing a framework for studying metabolic control of pulmonary vascular disease.

8701 records 1/581 page Next 12345 下5页 Last page